Meg_Butler

Immunology & Immunotherapy PhD student👩🏽‍🔬
Moss Lab, University of Birmingham

[Meg_Butler @Meg_Butler96]

Our latest study published in Nature Immunology ! Looking at the immune responses to SARS-CoV-2 infection in children.
https://t.co/rPhRW6tP1D

[Meg_Butler @Meg_Butler96]

Great couple of days at @BSI_TumourImm !!

[BSI Tumour Immunology @BSI_TumourImm]

Wow! What a meeting!! #TumourMicroenvironment24

Thanks to everyone who took part! We're looking forward to the next one already! 🥳

And congrats to our amazing winners! 🤩
Charles Earnshaw
@Capitani_L
@RobWiesheu
@ToshiM32
@Meg_Butler96

@bsicongress

[Anna Obenauf @obenaufa]

"This is why non-immunologists hate immunologists..." The fantastic @EJohnWherry explains the basics of cancer immunology with a focus on T cells in his beautiful and extremely clear lecture @AACR #AACR22. I really recommend watching it, it's a gem - both in content and delivery.

[Nature Portfolio @NaturePortfolio]

A study in @NatImmunol shows that immune responses to SARS-CoV-2 are higher in children, retained for 12 months or longer and can neutralize Alpha, Beta and Delta variants. https://t.co/d6Nmj0nCKv

[Alex Dowell @AlexD_81]

Early Christmas present having this finally come out, thanks to everyone that helped make this possible @Meg_Butler96 @jmzuo73 @VivaldiBham @ShamezLadhani @paulmos63832199 https://t.co/OW9sVkZNe7

[Nature Immunology @NatImmunol]

SARS-CoV-2 infection is milder in children. Dowell et al. show that immune responses are higher in children, retained for 12 months or longer and can neutralize Alpha, Beta and Delta variants. https://t.co/qCJLiAP5Ij & see the Research Briefing https://t.co/gQTi6B7iLU

[Jianmin @jmzuo73]

Well done! @AlexD_81 @VivaldiBham @Meg_Butler96 @ShamezLadhani @paulmos63832199

Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection | Nature Immunology https://t.co/wa8RZ75Cfh

[Azar Jadir @AzarJad1]

So great seeing the impact of our research!

[Moss Vivaldi @VivaldiBham]

Our second paper is now out in pre-print!

https://t.co/waYjf9Owhp

Prior SARS-CoV-2 infection increases strength and quality of immune response in double vaccinated care home staff and residents, reveals study https://t.co/rgEd8y2Z0K via @unibirmingham

[Moss Vivaldi @VivaldiBham]

Some of the Vivaldi team presenting our research at the @britsocimm this year!

[Meg_Butler @Meg_Butler96]

Also some of my high dimensional analysis is on poster 510 that I'm very proud of 👩🏽‍🔬🤗

[Meg_Butler @Meg_Butler96]

Come see poster 511 at BSI this year! Using high parameter flow and ICS to phenotype T cell responses following second dose covid vax!👩🏽‍🔬

[Meg_Butler @Meg_Butler96]

@Meg_Whitehouse0 @EdConferenceUoB Ah amazing!! Proud of you!!

[Nature Immunology @NatImmunol]

The contribution of T cells to the SARS-CoV-2 response remains an important and unresolved question. Moss and colleagues examine T cell and antibody kinetics in a large cohort of patients with COVID-19 and find robust and durable T cell responses https://t.co/j8fkfet9uc

[Darrion Nguyen @lab_shenanigans]

y’all don’t understand how much i love this video 😂👌🏽

[Dr. Tara C. Smith @aetiology]

Checkmate, scientists.

[Dr. Shannon Romano, PhD (she/her) @sromano23]

It’s ok mini heat block, nobody’s ok.

[British Society for Immunology @britsocimm]

What is an RNA #vaccine? 🤔

The Pfizer-BioNTech #COVID19 vaccine uses this type of technology to train the immune system

Our new infographic explains how this type of vaccine works. You can download & share it to help strengthen public understanding 👉https://t.co/jpOjBsJeu7

[UK-CIC @UKCICstudy]

Cellular (T cell) immunity to #SARSCoV2 is likely to be present within most adults six months after primary infection, suggests a new pre-print released today by #UKCIC and Public Health England (@unibirmingham @PHE_uk @ManchesterCRF)

https://t.co/4beRpy1bvF 1/🧵

[Guardian Science @guardianscience]

T-cell Covid immunity 'present in adults six months after first infection' https://t.co/QTB44Z6yFQ